OCTREOTIDE AND BROMOCRIPTINE IN PATIENTS WITH STAGE D2 PROSTATE-CANCER WHO RELAPSED DURING TREATMENT WITH FLUTAMIDE AND CASTRATION

被引：13

作者：

DUPONT, A

BOUCHER, H

CUSAN, L

LACOURCIERE, Y

EMOND, J

LABRIE, F

机构：

[1] UNIV LAVAL,MED CTR,DEPT MED,QUEBEC CITY G1V 4G2,QUEBEC,CANADA

[2] UNIV LAVAL,MED CTR,DEPT NUCL MED,QUEBEC CITY G1V 4G2,QUEBEC,CANADA

[3] UNIV LAVAL,MED CTR,DEPT RADIOL,QUEBEC CITY G1V 4G2,QUEBEC,CANADA

[4] UNIV LAVAL,MED CTR,DEPT UROL,QUEBEC CITY G1V 4G2,QUEBEC,CANADA

来源：

关键词：

D O I：

10.1016/0277-5379(90)90145-J

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：770 / 771

页数：2

共 4 条

[1]

FLEISS JL, 1981, STAT METHODS RATES P, P13

[2] EARLY TERMINATION OF A PHASE-II CLINICAL-TRIAL [J].

HILSENBECK, SG .

CONTROLLED CLINICAL TRIALS, 1988, 9 (03) :177-188

SCHALLY, AV ;

REDDING, TW .

[4]

SLACK NH, 1984, UROL CLIN N AM, V11, P337